(Q40143875)

17 September 2017

Myasthenia gravis and HLA antigens in American blacks and other races (English)

1 reference

17 September 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334696

1 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(84)80012-0

1 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(84)80012-0

1 October 2023

author name string

F. T. Christiansen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334696

1 October 2023

M. S. Pollack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334696

1 October 2023

M. J. Garlepp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334696

1 October 2023

R. L. Dawkins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334696

1 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6334696

1 October 2023

publication date

1 December 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0165572884800120?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0165-5728(84)80012-0

https://api.elsevier.com/content/article/PII:S0165572884800120?httpAccept=text/plain

1 October 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0165-5728(84)80012-0

Journal of Neuroimmunology

1 October 2023

published in

1 reference

17 September 2017

7

1 reference

17 September 2017

121-129

1 reference

17 September 2017

2-3

1 reference

HLA, anti-DNA, and complement in myasthenia gravis

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

Disease associations with complotypes, supratypes and haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

Myasthenia Gravis, Autoantibodies, and HL-A Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

The biologic significance of HL-A antigen markers in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

Autoimmunity in ocular and generalised myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

The diagnostic significance of autoantibodies to the acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

HLA antigens and myasthenia gravis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

Genetic control of suppressor lymphocyte function in myasthenia gravis: Relationship of impaired suppressor function to and cold reactive lymphocytotoxic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2884%2980012-0

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference